Ba D.M., Gao X., Al-Shaar L., Muscat J., Chinchilli V.M., Ssentongo P., Zhang X., Liu G., Beelman R.B., Richie J.P. Prospective study of dietary mushroom intake and risk of mortality: results from continuous National Health and Nutrition Examination Survey (NHANES) 2003-2014 and a meta-analysis. Nutrition Journal. 2021;20(1):80.
Rationale
Mushrooms are the main dietary source of ergothioneine and glutathione; the "eat mushrooms, live longer" hypothesis needed prospective human data.
Methods
NHANES 2003–2014, n=30,378; intake by up to two 24-h recalls; outcome all-cause mortality via NDI linkage; Cox models with demographic, lifestyle, diet-quality and energy adjustments. Parallel random-effects meta-analysis with four other cohorts.
Results
- 2,855 deaths over 6.7 y; own-cohort estimate non-significant: HR 0.84 (0.67–1.06).
- Pooled 5-cohort estimate (601,893): RR 0.94 (0.91–0.98) — about 6% lower all-cause mortality.
Conclusions
Pooled prospective data associate mushroom intake with a small mortality reduction; the single large US cohort alone did not reach significance.
Worth noting
An honest "weak signal" card: the authors' own cohort does not confirm the link (CI crosses 1) — significance appears only after pooling, and the pooled effect is 6%. Intake measured by one or two 24-h recalls is very noisy for an episodically eaten food, biasing toward null; residual confounding by overall lifestyle pushes the other way. Practical reading: the data don't contradict a modest benefit of mushrooms in the diet, but "mushrooms reduce mortality" overstates what was shown.